| Variable |
Overall patients (n = 51) |
Stage I hypertensives (n = 36) |
Stage II hypertensives (n = 15) |
p valuea |
|
| Gender |
|||||
| Male, n (%) |
30 (58.8) |
17 (47.2) |
13 (86.7) |
<0.05 |
|
| Female, n (%) |
21 (41.2) |
19 (52.8) |
2 (13.3) |
||
| Systolic blood pressure in mmHg, mean ± SD |
156.7 ± 2 |
152 ± 3 |
168 ± 5 |
<0.05 |
|
| Diastolic blood pressure in mmHg, mean ± SD |
96.9 ± 3 |
94 ± 5 |
104 ± 6 |
<0.05 |
|
| Symptoms of sleep-disordered breathing |
|||||
| No symptoms, n (%) |
24 (47.1) |
20 (55.5) |
4 (26.7) |
<0.05 |
|
| Disruptive snoring, n (%) |
22 (43.1) |
13 (36.1) |
9 (60.0) |
<0.05 |
|
| Frequent awakenings, n (%) |
10 (19.6) |
6 (16.7) |
4 (26.7) |
<0.05 |
|
| Morning headaches, n (%) |
18 (35.3) |
10 (27.8) |
8 (53.3) |
<0.05 |
|
| Excessive daytime sleepiness, n (%) |
11 (21.6) |
6 (16.7) |
5 (33.3) |
<0.05 |
|
| Self-reported apneas, n (%) |
6 (11.8) |
2 (5.6) |
4 (26.7) |
<0.05 |
|
| Duration of symptoms of sleep-disordered breathing |
|||||
| Asymptomatic, n (%) |
24 (47.1) |
20 (55.5) |
4 (26.7) |
0.05 |
|
| <6 months, n (%) |
5 (9.8) |
4 (11.1) |
1 (6.7) |
<0.05 |
|
| 6 - 12 months, n (%) |
9 (17.6) |
5 (13.9) |
4 (26.7) |
n.s. |
|
| >12 months, n (%) |
13 (25.5) |
7 (19.4) |
6 (40.0) |
<0.05 |
|
| Epworth Sleepiness Scale (ESS) score |
|||||
| 0 - 10 [No chances of dozing], n (%) |
25 (49.0) |
21 (58.3) |
4 (26.7) |
n.s. |
|
| 11 - 14 [Slight chances of dozing], n (%) |
13 (25.5) |
8 (22.2) |
5 (33.3) |
n.s. |
|
| 15 - 18 [Moderate chances of dozing], n (%) |
7 (13.7) |
4 (11.1) |
3 (20.0) |
n.s. |
|
| 19 - 24 [High chances of dozing], n (%) |
6 (11.8) |
3 (8.3) |
3 (20.0) |
<0.05 |
|
| Total sleep time in minutes, mean ± SD |
282.6 ± 32.6 |
288.5 ± 37.9 |
268.3 ± 27.9 |
n.s. |
|
| Sleep latency time in minutes, mean ± SD |
12.4 ± 0.90 |
12.5 ± _0.80 |
12.2 ± 0.86 |
n.s. |
|
| REM sleep latency time in minutes, mean ± SD |
111.2 ± 0.8 |
109.9 ± 0.78 |
114.4 ± 0.67 |
<0.05 |
|
| Snore time in minutes, mean ± SD |
95.9 ± 32.1 |
90.8 ± 32.1 |
108.6 ± 29.5 |
<0.05 |
|
| Apnea Hypopnea Index (AHI) score |
|||||
| <5 events/hour, n (%) |
14 (27.5) |
11 (30.5) |
3 (20.0) |
n.s. |
|
| 5- < 15 events/hour, n (%) |
25 (49.0) |
19 (52.8) |
6 (40.0) |
n.s. |
|
| 15- < 30 events/hour, n (%) |
9 (17.6) |
5 (13.9) |
4 (26.7) |
n.s. |
|
| ≥30 events/hour, n (%) |
3 (5.9) |
1 (2.8) |
2 (13.3) |
n.s. |
|
| AHI (events per hour), mean ± SD |
10.08 ± 7.4 |
8.48 ± 5.8 |
13.9 ± 9.5 |
n.s. |
|
| Patients with nocturnal oxygen desaturation, n (%) |
17 (33.3%) |
9 (25.0) |
8 (53.3) |
n.s. |
|
| Lowest oxygen saturation levels, mean ± SD |
89.7 ± 6.0 |
90.9 ± 4.8 |
85.6 ± 7.0 |
<0.05 |
|
| C-reactive protein levels in mg/dL, mean ± SD |
0.81 ± 0.08 |
0.73 ± 0.06 |
0.99 ± 0.1 |
<0.05 |
|